Company Profile
Organogenesis Stock Price, News & Analysis
- Ticker:
- ORGO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Organogenesis is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
2.43 USD (0.00%)
Close
Last updated: June 23, 2026 at 00:00
312.68M USD
Market cap
Why the stock is moving
ORGO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Organogenesis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Organogenesis is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Organogenesis follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Organogenesis sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
Source: Organogenesis
- 02
- 03
Organogenesis Applauds CMS’s Significant Step In Payment Reform
Source: Organogenesis
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Organogenesis (ORGO)?
Organogenesis (ORGO) most recently closed at 2.43 USD, a 0.00% move versus the previous session.
What is the market cap of Organogenesis (ORGO)?
Organogenesis currently has a market capitalization of 312.68M USD on BioPharmSignal.
What does Organogenesis do?
Organogenesis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ORGO stock listed?
Organogenesis (ORGO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Organogenesis is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Organogenesis?
Organogenesis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Organogenesis targeting with Organogenesis?
Organogenesis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.